Literature DB >> 10082897

Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission.

E Ericson1, S Ahlenius.   

Abstract

The objective was to examine effects of galaninrat on forebrain monoamine synthesis and on spontaneous locomotor activity in the rat. The rate of monoamine synthesis was estimated by measuring the accumulation of l-DOPA and 5-HTP, following inhibition of cerebral aromatic l-amino acid decarboxylase by means of NSD-1015 (100 mg kg-1 i.p.), after i.c.v. or intracerebral administration of galanin in adult male Wistar rats. Spontaneous locomotor activity was observed in an automated open-field arena ( approximately 0.5 m2). The i.c.v. administration of galanin (0.5-5.0 nmol bilaterally) produced a dose-dependent, statistically significant, increase in DOPA accumulation throughout the neostriatum, and in the olfactory bulb, indicating an increase in the rate of DA synthesis. No increase was observed in brain areas where noradrenaline is the predominant catecholamine, such as the neocortex or the ventral hippocampus. In addition, there was a tendency for an increase in 5-HTP accumulation in the dorso-lateral neostriatum and in the accumbens. The same i.c.v. administration of galanin produced a dose-dependent, and statistically significant, decrease in spontaneous locomotor activity. The effect on forebrain DA synthesis could also be produced by local bilateral application of galanin (2x1 nmol) into the ventral tegmental area, but not the nucleus accumbens (2x2 nmol). There were no effects on forebrain DOPA or 5-HTP accumulation by the local application of galanin into the locus coeruleus, or into the dorsal raphe nucleus. It is concluded that the neuropeptide galanin modulates forebrain dopaminergic neurotransmission. The effect appears to be mediated at the somato-dendritic level of the meso-neostriatal pathway, and could perhaps be utilized to normalize perturbations ascribed to dysfunction in this neuronal pathway, such as schizophrenia. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082897     DOI: 10.1016/s0006-8993(99)01144-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin.

Authors:  Christian Brabant; Anna S Kuschpel; Marina R Picciotto
Journal:  Behav Neurosci       Date:  2010-12       Impact factor: 1.912

Review 2.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

3.  Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.

Authors:  Allison B Gold; E Paul Wileyto; Adriana Lori; David Conti; Joseph F Cubells; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

4.  Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference.

Authors:  Nichole M Neugebauer; Robert M Henehan; Claire A Hales; Marina R Picciotto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-21       Impact factor: 3.533

5.  Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Authors:  Emily B Einstein; Yukiko Asaka; Mark F Yeckel; Michael J Higley; Marina R Picciotto
Journal:  Eur J Neurosci       Date:  2013-02-07       Impact factor: 3.386

6.  Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1.

Authors:  K Mitsukawa; X Lu; T Bartfai
Journal:  Neuroscience       Date:  2009-03-09       Impact factor: 3.590

7.  The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.

Authors:  Venetia Zachariou; Darlene H Brunzell; Jessica Hawes; Diann R Stedman; Tamas Bartfai; Robert A Steiner; David Wynick; Ulo Langel; Marina R Picciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 8.  Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Authors:  Marina R Picciotto; Christian Brabant; Emily B Einstein; Helen M Kamens; Nichole M Neugebauer
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

9.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

10.  Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice.

Authors:  Roopashree Narasimhaiah; Helen M Kamens; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.